Greg Patterson
Directeur/Bestuurslid bij DEVERON CORP.
Vermogen: 1 M $ op 31-05-2024
Profiel
Greg Patterson is the founder of A&L Canada Laboratories, Inc. He currently holds a position as Director at Deveron Corp.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DEVERON CORP.
8.75% | 29-12-2023 | 13 688 182 ( 8.75% ) | 1 M $ | 31-05-2024 |
Actieve functies van Greg Patterson
| Bedrijven | Functie | Begin |
|---|---|---|
| DEVERON CORP. | Directeur/Bestuurslid | 20-05-2022 |
A&L Canada Laboratories, Inc.
 A&L Canada Laboratories, Inc. Medical/Nursing ServicesHealth Services Part of Deveron Corp., A&L Canada Laboratories, Inc. provides testing laboratory services. The company is based in London, Canada. A&L Canada Laboratories was acquired by Deveron Corp. from 2736130 Ontario, Inc. on May 20, 2022 for $37.69 million. The Canadian company was founded by Greg Patterson. Greg Patterson has been the CEO since incorporation. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DEVERON CORP. | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
A&L Canada Laboratories, Inc.
A&L Canada Laboratories, Inc. Medical/Nursing ServicesHealth Services Part of Deveron Corp., A&L Canada Laboratories, Inc. provides testing laboratory services. The company is based in London, Canada. A&L Canada Laboratories was acquired by Deveron Corp. from 2736130 Ontario, Inc. on May 20, 2022 for $37.69 million. The Canadian company was founded by Greg Patterson. Greg Patterson has been the CEO since incorporation. | Health Services |
